Related Experiment Video
Updated: Jul 3, 2026

A Multicenter MRI Protocol for the Evaluation and Quantification of Deep Vein Thrombosis
Published on: June 2, 2015
Risk of thrombogenicity among nonionic radiocontrast agents
Alexander Georgakis1, Rasih Atilla Ener, Jianguo Jin
1Division of Cardiology, Temple University School of Medicine, Philadelphia, Pennsylvania, USA.
Abstract:
Several contrast agents have been approved in the United States for radiographic imaging purposes. Most of the older ionic, high-osmolar contrast agents are no longer used because of their side effect profile. Therefore, newer nonionic, low or iso-osmolar contrast agents have been widely accepted as an alternative due to their improved tolerability and safety. We investigated the thrombogenicity of the 6 different nonionic radiocontrast media in terms of their platelet reactivity and noted some minor differences among them. In the 50% contrast concentration group, all of the nonionic contrast agents inhibited aggregation, whereas in the 10% contrast concentration group, all agents showed similar aggregation curves in comparison to the normal control. At 50% contrast concentration, the inhibitory effect of aggregation appeared to be related to the inhibition of calcium mobilization, which may be one of the mechanistic effects.
Related Concept Videos
Radiological Investigation I: X-ray and CT
Imaging Studies III: Computed Tomography
Imaging Studies for Cardiovascular System V: CT
Imaging Studies I: CT and MRI
Description of the Procedures
Computed Tomography (CT) scan:
Computed Tomography (CT) scans use X-ray technology to generate detailed images of bones, organs, and tissues. During the scan, the patient lies on a moving table...
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Therapeutic Index
